StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Rockwell Medical gross margin

Gross margin is gross profit as a percentage of revenue.

Rockwell Medical's gross margin for the twelve months ending Jun 30, 2026 was 17.7%. For fiscal 2025 it was 16.9%, against 17.2% the year before. The highest annual figure on record is 17.2% in fiscal 2024.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202516.9%−0.3
FY2024Dec 31, 202417.2%+6.8
FY2023Dec 31, 202310.4%+4.8
FY2022Dec 31, 20225.6%+9.5
FY2021Dec 31, 2021-3.9%−8.3
FY2020Dec 31, 20204.4%−0.2
FY2019Dec 31, 20194.6%+7.1
FY2018Dec 31, 2018-2.5%−9.0
FY2017Dec 31, 20176.5%−6.2
FY2016Dec 31, 201612.7%−3.5
FY2015Dec 31, 201516.1%+0.4
FY2014Dec 31, 201415.8%+3.1
FY2013Dec 31, 201312.7%−0.7
FY2012Dec 31, 201213.4%+1.9
FY2011Dec 31, 201111.5%−5.0
FY2010Dec 31, 201016.6%+2.1
FY2009Dec 31, 200914.4%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202618.2%+2.7
Q1 FY2026Mar 31, 202616.7%+0.6
Q4 FY2025Dec 31, 202521.1%+6.4
Q3 FY2025Sep 30, 202514.3%−7.8
Q2 FY2025Jun 30, 202515.6%−2.0
Q1 FY2025Mar 31, 202516.1%+2.6
Q4 FY2024Dec 31, 202414.7%+1.7
Q3 FY2024Sep 30, 202422.0%+12.8
Q2 FY2024Jun 30, 202417.6%+11.9
Q1 FY2024Mar 31, 202413.5%+0.3
Q4 FY2023Dec 31, 202313.0%+0.9
Q3 FY2023Sep 30, 20239.3%+5.1
Q2 FY2023Jun 30, 20235.7%−3.6
Q1 FY2023Mar 31, 202313.2%+18.1
Q4 FY2022Dec 31, 202212.1%+26.7
Q3 FY2022Sep 30, 20224.2%+6.2
Q2 FY2022Jun 30, 20229.3%+11.1
Q1 FY2022Mar 31, 2022-4.9%−7.5
Q4 FY2021Dec 31, 2021-14.6%−17.1
Q3 FY2021Sep 30, 2021-2.1%−4.3
Q2 FY2021Jun 30, 2021-1.7%−7.3
Q1 FY2021Mar 31, 20212.6%−4.4
Q4 FY2020Dec 31, 20202.5%−4.6
Q3 FY2020Sep 30, 20202.3%+2.4
Q2 FY2020Jun 30, 20205.5%+0.6
Q1 FY2020Mar 31, 20207.0%+0.5
Q4 FY2019Dec 31, 20197.2%+0.2
Q3 FY2019Sep 30, 2019-0.1%−11.9
Q2 FY2019Jun 30, 20194.9%+31.9
Q1 FY2019Mar 31, 20196.5%+11.3
Q4 FY2018Dec 31, 20187.0%+15.3
Q3 FY2018Sep 30, 201811.8%+4.5
Q2 FY2018Jun 30, 2018-26.9%−38.2
Q1 FY2018Mar 31, 2018-4.8%−21.0
Q4 FY2017Dec 31, 2017-8.3%−23.1
Q3 FY2017Sep 30, 20177.3%−5.0
Q2 FY2017Jun 30, 201711.3%–
Q1 FY2017Mar 31, 201716.2%–
Q4 FY2016Dec 31, 201614.8%–
Q3 FY2016Sep 30, 201612.3%–

More Rockwell Medical figures

See a number that looks wrong?